Search Medical Condition
Please enter condition
Please choose location from dropdown

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (262) clinical trials

A randomised, double-blind, placebo-controlled trial to evaluate the effect of tralokinumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.  

Phase N/A

This study is testing an investigational drug for Peanut Allergy.

Phase

Unhappy with your options for eczema? Considering different options? Wake Research is enrolling volunteers in a study of the efficacy, safety and tolerability of an investigational ointment for mild to moderate eczema, also called atopic dermatitis. Your participation in the study could last up to three months. You’ll receive study-related ...

Phase N/A

Do you or a loved one have eczema (also called "atopic dermatitis")? If so, you might be interested in a clinical study now enrolling. Wake Research is testing a study drug for eczema and we need people to take part.  

Phase N/A

Pediatric Fall Allergy Study for Children ages 6-11 years old

Phase N/A

Chronic itch associated with Prurigo Nodularis

Phase

This study is a 2-part (parts A and B) phase 2/3 study to evaluate the safety, pharmacokinetics (PK) and efficacy of dupilumab in patients 6 months to less than 6 years of age with severe atopic dermatitis (AD).

Phase

The main objective of the trial is to demonstrate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) in participants ≥6 years to <12 years of age with severe atopic dermatitis (AD). The secondary objective is to assess the safety of dupilumab administered concomitantly with TCS in patients ≥6 ...

Phase

A randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability and immunologic effects of HAL-MPE1 subcutaneous immunotherapy in adult and pediatric subjects with peanut allergy.

Phase

Children and adolescents with HDM allergic asthma are asked to participate in a research study being conducted by Cohen Children's Medical Center of New York.

Phase N/A